While human clinical trials remain limited, the extensive body of animal research suggests potential applications in gastrointestinal healing, tendon and ligament repair, muscle recovery, neuroprotection, and cardiovascular health
Pre-Blend Dose Assessment (10 units / 0.10 mL daily) Component GHK-Cu Per-dose from Blend ~1.67 mg Typical Standalone 1-2 mg daily Assessment In range Component BPC-157 Per-dose from Blend ~0.33 mg Typical Standalone 0.25-0.5 mg daily Assessment In range Component TB-500 Per-dose from Blend ~0.33 mg Typical Standalone 2-5 mg per injection, 2x/week Assessment Below standalone injury range The 5:1:1 blend is convenience- and skin-focused
GHK and GHK-Cu didnt cause any significant changes in the extracellular protein concentration of IL-1, IL8, HSPA1A
Any medication can have potential side effects, but those of 5 Amino 1MQ are minimal
Step both compounds up slowly over the next 16 weeks to reach maintenance
Usually resolves quickly